Three healthcare advertising agencies came together at South By Southwest to create a wide new range of possibilities for the ever-growing Health and MedTech Track.
For breast cancer survivors, the risk of recurrence may be tied to how many hours they fast at night, a new study suggests.
<span class="articleLocation”>(Reuters Health) – For breast cancer survivors, the risk of recurrence may be tied to how many hours they fast at night, a new study suggests. Women in the study were more likely to have their breast cancer come back if they fasted overnight for less than 13 hours, researchers found. While prolonged fasting […]
The U.S. Federal Trade Commission said it filed a complaint in a district court accusing Endo International Plc of violating antitrust laws by striking “pay-for-delay” deals.
Takeda Pharmaceuticals U.S.A. announced a multi-year research partnership with two world-leading academic centers with a proven long-term commitment to IBD research and care.
GlaxoSmithKline is to adopt a graduated approach to patenting its medicines, depending on the wealth of different countries, in order to make drugs more affordable in the developing world. Britain’s biggest drugmaker said on Thursday it would not file patents in low-income states, leaving the way clear for generic companies to make cheap copies […]
Phase 3 Study Findings Demonstrate Treatment with Baricitinib Results in Significant Improvements for Patients with Rheumatoid Arthritis Who Had Inadequate Response to Biologics Pivotal RA-BEACON Study Published in New England Journal of Medicine 07:00 ET from Eli Lilly and Company; Incyte Corporation INDIANAPOLIS, March 31, 2016 /PRNewswire/ — Eli Lilly and Company (NYSE: LLY) […]
1,000+ Women are Suing Johnson & Johnson for Allegedly Covering Up Baby Powder Cancer Risk for Decades March 31, 2016By Alex Keown, BioSpace.com Breaking News Staff WASHINGTON – More than 1,000 women have joined a lawsuit against Johnson & Johnson (JNJ) claiming the company failed to provide information about risks of ovarian […]
Jazz Pharmaceuticals Announces FDA Approval of Defitelio (defibrotide sodium) for the Treatment of Hepatic Veno-Occlusive Disease (VOD) with Renal or Pulmonary Dysfunction Following Hematopoietic Stem-Cell Transplantation (HSCT) First and Only FDA-Approved Therapy for Patients with this Rare, Potentially Fatal Complication DUBLIN, March 30, 2016 /PRNewswire/ — Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that […]
The U.S. Food and Drug Administration said it would allow the use of an experimental test to screen donated blood for the Zika virus.